A Telehealth tDCS Approach to Decrease Cannabis Use: Towards Reducing Multiple Sclerosis Disability

Go Back to All Clinical Trials

A Telehealth tDCS Approach to Decrease Cannabis Use: Towards Reducing Multiple Sclerosis Disability

Brief description of study

The purpose of this study is to determine if transcranial direct current stimulation, or tDCS, can be used to treat cannabis use disorder (CUD) in patients living with multiple sclerosis (MS). There are currently no established standard-of-care treatments for cannabis use reduction, including for the MS patient. This study will evaluate whether tDCS combined with mindfulness meditation results in decreased distress and, in turn, decreased cannabis use. tDCS is a safe, noninvasive (does not enter your body) brain stimulation that uses a small handheld tDCS device to deliver a mild electrical current through a headset to the brain to help improve brain activity.

Clinical Study Identifier: s21-01028

ClinicalTrials.gov Identifier: NCT05005013

Principal Investigator: Leigh E. Charvet.

Other Investigators: Robert W Charlson, Giuseppina Pilloni.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies